Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Hepatitis C Drug Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Hepatitis C Drug Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Hepatitis C Drug Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Hepatitis C Drug Market-Segmentation by Type 5.1 Oral 5.2 Injection 5.3 Other 6 Global Hepatitis C Drug Market-Segmentation by Application 6.1 Hospitals 6.2 Private labs 6.3 Physician Offices 6.4 Public Health Labs 6.5 Blood Banks 7 Global Hepatitis C Drug Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Basel GlaxoSmith 8.1.1 Basel GlaxoSmith Profile 8.1.2 Basel GlaxoSmith Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Basel GlaxoSmith Product/Solution Launches and Enhancements Analysis 8.1.4 Basel GlaxoSmith Business Overview/Recent Development/Acquisitions 8.2 Medivir AB 8.2.1 Medivir AB Profile 8.2.2 Medivir AB Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Medivir AB Product/Solution Launches and Enhancements Analysis 8.2.4 Medivir AB Business Overview/Recent Development/Acquisitions 8.3 Johnson & Johnson 8.3.1 Johnson & Johnson Profile 8.3.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis 8.3.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions 8.4 Gilead Sciences 8.4.1 Gilead Sciences Profile 8.4.2 Gilead Sciences Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Gilead Sciences Product/Solution Launches and Enhancements Analysis 8.4.4 Gilead Sciences Business Overview/Recent Development/Acquisitions 8.5 Kenilworth 8.5.1 Kenilworth Profile 8.5.2 Kenilworth Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Kenilworth Product/Solution Launches and Enhancements Analysis 8.5.4 Kenilworth Business Overview/Recent Development/Acquisitions 8.6 Achillion 8.6.1 Achillion Profile 8.6.2 Achillion Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Achillion Product/Solution Launches and Enhancements Analysis 8.6.4 Achillion Business Overview/Recent Development/Acquisitions 8.7 Kadmon 8.7.1 Kadmon Profile 8.7.2 Kadmon Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Kadmon Product/Solution Launches and Enhancements Analysis 8.7.4 Kadmon Business Overview/Recent Development/Acquisitions 8.8 Bristol-Myers Squibb 8.8.1 Bristol-Myers Squibb Profile 8.8.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis 8.8.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions 8.9 Roche 8.9.1 Roche Profile 8.9.2 Roche Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Roche Product/Solution Launches and Enhancements Analysis 8.9.4 Roche Business Overview/Recent Development/Acquisitions 8.10 AbbVie 8.10.1 AbbVie Profile 8.10.2 AbbVie Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 AbbVie Product/Solution Launches and Enhancements Analysis 8.10.4 AbbVie Business Overview/Recent Development/Acquisitions 8.11 Genentech 8.11.1 Genentech Profile 8.11.2 Genentech Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 Genentech Product/Solution Launches and Enhancements Analysis 8.11.4 Genentech Business Overview/Recent Development/Acquisitions 8.12 Merck & Co 8.12.1 Merck & Co Profile 8.12.2 Merck & Co Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 Merck & Co Product/Solution Launches and Enhancements Analysis 8.12.4 Merck & Co Business Overview/Recent Development/Acquisitions 8.13 Boehringer Ingelheim 8.13.1 Boehringer Ingelheim Profile 8.13.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2014-2019E 8.13.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis 8.13.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions 9 Global Hepatitis C Drug Market-Segmentation by Geography 10 North America 10.1 North America Hepatitis C Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Hepatitis C Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Hepatitis C Drug Production Analysis from 2014-2019E 10.4 North America Hepatitis C Drug Consumption Analysis from 2014-2019E 10.5 North America Hepatitis C Drug Import and Export from 2014-2019E 10.6 North America Hepatitis C Drug Value, Production and Market Share by Type (2014-2019E) 10.7 North America Hepatitis C Drug Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Hepatitis C Drug by Country (United States, Canada) 10.8.1 North America Hepatitis C Drug Sales by Country (2014-2019E) 10.8.2 North America Hepatitis C Drug Consumption Value by Country (2014-2019E) 10.9 North America Hepatitis C Drug Market PEST Analysis 11 Europe 11.1 Europe Hepatitis C Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Hepatitis C Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Hepatitis C Drug Production Analysis from 2014-2019E 11.4 Europe Hepatitis C Drug Consumption Analysis from 2014-2019E 11.5 Europe Hepatitis C Drug Import and Export from 2014-2019E 11.6 Europe Hepatitis C Drug Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Hepatitis C Drug Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Hepatitis C Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Hepatitis C Drug Sales by Country (2014-2019E) 11.8.2 Europe Hepatitis C Drug Consumption Value by Country (2014-2019E) 11.9 Europe Hepatitis C Drug Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Hepatitis C Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Hepatitis C Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Hepatitis C Drug Production Analysis from 2014-2019E 12.4 Asia-Pacific Hepatitis C Drug Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Hepatitis C Drug Import and Export from 2014-2019E 12.6 Asia-Pacific Hepatitis C Drug Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Hepatitis C Drug Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Hepatitis C Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Hepatitis C Drug Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Hepatitis C Drug Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Hepatitis C Drug Market PEST Analysis 13 Latin America 13.1 Latin America Hepatitis C Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Hepatitis C Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Hepatitis C Drug Production Analysis from 2014-2019E 13.4 Latin America Hepatitis C Drug Consumption Analysis from 2014-2019E 13.5 Latin America Hepatitis C Drug Import and Export from 2014-2019E 13.6 Latin America Hepatitis C Drug Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Hepatitis C Drug Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Hepatitis C Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Hepatitis C Drug Sales by Country (2014-2019E) 13.8.2 Latin America Hepatitis C Drug Consumption Value by Country (2014-2019E) 13.9 Latin America Hepatitis C Drug Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Hepatitis C Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Hepatitis C Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Hepatitis C Drug Production Analysis from 2014-2019E 14.4 Middle East & Africa Hepatitis C Drug Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Hepatitis C Drug Import and Export from 2014-2019E 14.6 Middle East & Africa Hepatitis C Drug Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Hepatitis C Drug Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Hepatitis C Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Hepatitis C Drug Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Hepatitis C Drug Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Hepatitis C Drug Market PEST Analysis 15 Future Forecast of the Global Hepatitis C Drug Market from 2018-2026 15.1 Future Forecast of the Global Hepatitis C Drug Market from 2019-2026 Segment by Region 15.2 Global Hepatitis C Drug Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Hepatitis C Drug Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Hepatitis C Drug Market Value ($) and Growth Rate of Hepatitis C Drug from 2014-2026 Global Hepatitis C Drug Production and Growth Rate Segment by Product Type from 2014-2026F Global Hepatitis C Drug Consumption and Growth Rate Segment by Application from 2014-2019E Figure Hepatitis C Drug Picture Table Product Specifications of Hepatitis C Drug Table Driving Factors for this Market Table Industry News of Hepatitis C Drug Market Figure Value Chain Status of Hepatitis C Drug Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Hepatitis C Drug Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Hepatitis C Drug Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Oral of Hepatitis C Drug Figure Injection of Hepatitis C Drug Figure Other of Hepatitis C Drug Table Global Hepatitis C Drug Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Hepatitis C Drug Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospitals of Hepatitis C Drug Figure Private labs of Hepatitis C Drug Figure Physician Offices of Hepatitis C Drug Figure Public Health Labs of Hepatitis C Drug Figure Blood Banks of Hepatitis C Drug Table Global Hepatitis C Drug Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Hepatitis C Drug Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Hepatitis C Drug Figure Online Channel of Hepatitis C Drug Table Basel GlaxoSmith Profile (Company Name, Plants Distribution, Sales Region) Figure Basel GlaxoSmith Sales and Growth Rate from 2014-2019E Figure Basel GlaxoSmith Revenue ($) and Global Market Share from 2014-2019E Table Basel GlaxoSmith Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Medivir AB Profile (Company Name, Plants Distribution, Sales Region) Figure Medivir AB Sales and Growth Rate from 2014-2019E Figure Medivir AB Revenue ($) and Global Market Share from 2014-2019E Table Medivir AB Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region) Figure Johnson & Johnson Sales and Growth Rate from 2014-2019E Figure Johnson & Johnson Revenue ($) and Global Market Share from 2014-2019E Table Johnson & Johnson Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Gilead Sciences Profile (Company Name, Plants Distribution, Sales Region) Figure Gilead Sciences Sales and Growth Rate from 2014-2019E Figure Gilead Sciences Revenue ($) and Global Market Share from 2014-2019E Table Gilead Sciences Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Kenilworth Profile (Company Name, Plants Distribution, Sales Region) Figure Kenilworth Sales and Growth Rate from 2014-2019E Figure Kenilworth Revenue ($) and Global Market Share from 2014-2019E Table Kenilworth Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Achillion Profile (Company Name, Plants Distribution, Sales Region) Figure Achillion Sales and Growth Rate from 2014-2019E Figure Achillion Revenue ($) and Global Market Share from 2014-2019E Table Achillion Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Kadmon Profile (Company Name, Plants Distribution, Sales Region) Figure Kadmon Sales and Growth Rate from 2014-2019E Figure Kadmon Revenue ($) and Global Market Share from 2014-2019E Table Kadmon Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region) Figure Bristol-Myers Squibb Sales and Growth Rate from 2014-2019E Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2014-2019E Table Bristol-Myers Squibb Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Roche Profile (Company Name, Plants Distribution, Sales Region) Figure Roche Sales and Growth Rate from 2014-2019E Figure Roche Revenue ($) and Global Market Share from 2014-2019E Table Roche Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table AbbVie Profile (Company Name, Plants Distribution, Sales Region) Figure AbbVie Sales and Growth Rate from 2014-2019E Figure AbbVie Revenue ($) and Global Market Share from 2014-2019E Table AbbVie Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Genentech Profile (Company Name, Plants Distribution, Sales Region) Figure Genentech Sales and Growth Rate from 2014-2019E Figure Genentech Revenue ($) and Global Market Share from 2014-2019E Table Genentech Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Merck & Co Profile (Company Name, Plants Distribution, Sales Region) Figure Merck & Co Sales and Growth Rate from 2014-2019E Figure Merck & Co Revenue ($) and Global Market Share from 2014-2019E Table Merck & Co Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region) Figure Boehringer Ingelheim Sales and Growth Rate from 2014-2019E Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2014-2019E Table Boehringer Ingelheim Hepatitis C Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Hepatitis C Drug Production Value ($) by Region from 2014-2019E Table Global Hepatitis C Drug Production Value Share by Region from 2014-2019E Table Global Hepatitis C Drug Production by Region from 2014-2019E Table Global Hepatitis C Drug Consumption Value ($) by Region from 2014-2019E Table Global Hepatitis C Drug Consumption by Region from 2014-2019E Table North America Hepatitis C Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Hepatitis C Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Hepatitis C Drug Import and Export from 2014-2019E Table North America Hepatitis C Drug Value ($) by Type (2014-2019E) Table North America Hepatitis C Drug Production by Type (2014-2019E) Table North America Hepatitis C Drug Consumption by Application (2014-2019E) Table North America Hepatitis C Drug Consumption by Country (2014-2019E) Table North America Hepatitis C Drug Consumption Value ($) by Country (2014-2019E) Figure North America Hepatitis C Drug Market PEST Analysis Table Europe Hepatitis C Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Hepatitis C Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Hepatitis C Drug Import and Export from 2014-2019E Table Europe Hepatitis C Drug Value ($) by Type (2014-2019E) Table Europe Hepatitis C Drug Production by Type (2014-2019E) Table Europe Hepatitis C Drug Consumption by Application (2014-2019E) Table Europe Hepatitis C Drug Consumption by Country (2014-2019E) Table Europe Hepatitis C Drug Consumption Value ($) by Country (2014-2019E) Figure Europe Hepatitis C Drug Market PEST Analysis Table Asia-Pacific Hepatitis C Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Hepatitis C Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Hepatitis C Drug Import and Export from 2014-2019E Table Asia-Pacific Hepatitis C Drug Value ($) by Type (2014-2019E) Table Asia-Pacific Hepatitis C Drug Production by Type (2014-2019E) Table Asia-Pacific Hepatitis C Drug Consumption by Application (2014-2019E) Table Asia-Pacific Hepatitis C Drug Consumption by Country (2014-2019E) Table Asia-Pacific Hepatitis C Drug Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Hepatitis C Drug Market PEST Analysis Table Latin America Hepatitis C Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Hepatitis C Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Hepatitis C Drug Import and Export from 2014-2019E Table Latin America Hepatitis C Drug Value ($) by Type (2014-2019E) Table Latin America Hepatitis C Drug Production by Type (2014-2019E) Table Latin America Hepatitis C Drug Consumption by Application (2014-2019E) Table Latin America Hepatitis C Drug Consumption by Country (2014-2019E) Table Latin America Hepatitis C Drug Consumption Value ($) by Country (2014-2019E) Figure Latin America Hepatitis C Drug Market PEST Analysis Table Middle East & Africa Hepatitis C Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Hepatitis C Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Hepatitis C Drug Import and Export from 2014-2019E Table Middle East & Africa Hepatitis C Drug Value ($) by Type (2014-2019E) Table Middle East & Africa Hepatitis C Drug Production by Type (2014-2019E) Table Middle East & Africa Hepatitis C Drug Consumption by Application (2014-2019E) Table Middle East & Africa Hepatitis C Drug Consumption by Country (2014-2019E) Table Middle East & Africa Hepatitis C Drug Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Hepatitis C Drug Market PEST Analysis Table Global Hepatitis C Drug Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Hepatitis C Drug Production and Growth Rate Forecast by Region (2019-2026) Table Global Hepatitis C Drug Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Hepatitis C Drug Production and Growth Rate Forecast by Type (2019-2026) Table Global Hepatitis C Drug Consumption and Growth Rate Forecast by Application (2019-2026)